NexImmune, Inc. Profile Avatar - Palmy Investing

NexImmune, Inc.

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its p…

Biotechnology
US, Gaithersburg [HQ]

Resulting Ratios

6 Records · Starting from 2018
Loading...
End of NEXI's Analysis
CIK: 1538210 CUSIP: 65344D109 ISIN: US65344D2080 LEI: - UEI: -
Secondary Listings
NEXI has no secondary listings inside our databases.